Breadcrumb

CTB news banner

RI-MUHC team identifies new gene associated with risk of cardiovascular diseases

New study analyses millions of genetic variants in almost 300,000 individuals

Paving the way for COVID-19 research

RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2

RI-MUHC researcher earns Quebec’s highest honour for research in biomedicine

William Foulkes awarded 2020 Wilder Penfield Prize for research in the genetics of breast and ovarian cancer ...

Stem cells are the marrow of the TB pandemic, which still kills one person every 22 seconds

A new study finds that not only can stem cells be targeted for protective vaccination, but they can also ...

Recovering from sleep deprivation: What is the role of astrocytes?

A new RI-MUHC study uses sleep-deprived fruit flies to study regulation of rebound sleep

Dr. Nada Jabado recognized by UBC

International leader in the field of childhood brain cancers receives the Dr. Chew Wei Memorial Prize

Former RI-MUHC trainee named a member of the CIHR’s new nationwide Youth Advisory Council

Congratulations to Wajih Jawhar of the Cancer Research Program!

Gene therapy to restore sight coming to the Montreal Children's Hospital and to Quebec

Dozens of young patients will be among the first in Canada to benefit from this treatment, which improves vision...

RI-MUHC trainee earns prestigious MITACS fellowship

Congratulations to Catherine Argyriou!

Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill

Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery

From silent infection to rapid death: Why are some people more vulnerable to COVID-19?

Scientists discover genetic and immunological causes of 15 percent of life-threatening COVID-19 cases

15,000 COVID-19 tests produced by McGill University and the RI-MUHC: a step toward Canadian self-sufficiency

In July 2020, the McGill University Health Centre’s (MUHC's) Department of Clinical...

RI-MUHC researcher Maziar Divangahi honoured by the Royal Society of Canada

Recognition for high-level achievement in research into pulmonary infectious diseases

Canada Research Chairs Program announces new and renewed chairs

Congratulations to five RI-MUHC researchers!

Dr. Armen Aprikian appointed Clinical Lead, Rossy Cancer Network

A leading urologic oncologist and researcher takes the helm

Charles Bourque named President of the Canadian Association for Neuroscience

RI-MUHC researcher’s career is dedicated to advancing brain research

Study identifies strategies to reduce breast cancer growth and related skeletal lesions

RI-MUHC team publishes findings in the journal, Bone Research

Sodium found to regulate the biological clock of mice

New study by RI-MUHC researchers first to establish that physiological signals influence circadian rhythms

Novel gene therapy trial offers hope to patients with rare metabolic disease

Samuel is the first Canadian and the ninth patient worldwide to participate in the second phase of a study using gene...